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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the eFects of acupuncture for treating OAB in adults; and summarise the principal findings of relevant economic evaluations.
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B A C K G R O U N D
For a glossary of terms used, see Appendix 1.
Description of the condition
Overactive bladder (OAB) is defined by the International
Continence Society as "urinary urgency, usually accompanied
by frequency and nocturia, with or without urgency urinary
incontinence, in the absence of urinary tract infection or other
obvious pathology" (Abrams 2017). OAB can be further categorised
into "OAB-dry" (where urinary incontinence is absent) and "OAB-
wet" (where urinary incontinence is present) (Abrams 2017).
Abrams 2012 reported that urinary frequency accompanies OAB in
20% to 25% of cases, and nocturia in 70% to 75% of cases. Around
one in three people with OAB also experience urinary incontinence
(Irwin 2006).
OAB is common. An epidemiological study, the EPIC study, was
conducted in five countries (Canada, Sweden, Italy, Germany, and
the UK) and included 19,165 participants (Irwin 2006). It reported
11.8% of the population had OAB symptoms, with slightly more
women aFected (12.8%) than men (10.8%) (Irwin 2006). This is
equivalent to one in nine of the general adult population (Irwin
2006). The prevalence of OAB increases with age and symptoms are
reported to occur in 40% of men and 46% of women aged 65 years
or over (Sexton 2011).
The exact pathophysiology underlying OAB is not fully understood
and it is thought that several processes may contribute to
developing symptoms (Malde 2018). These processes include:
abnormal secretion of acetylcholine during bladder filling, which
may result in aFerent activation; compounds released by urothelial
cells, which may aFect cell signalling; alteration in smooth
muscle properties; abnormal aFerent activity resulting in increased
eFerent responses, which compromises voluntary bladder control;
and altered cognitive responses, specifically in the orbitofrontal
cortex.
OAB is most oLen present when there is no underlying neurological
disease; this is known as idiopathic OAB. However, it is also
sometimes associated with neurological conditions, including
stroke, Parkinson's disease, multiple sclerosis, and spinal cord
injury. People presenting with OAB should be screened to rule out
neurological causes (Tse 2016).
OAB is a long-term condition that reduces quality of life, leading
to increased anxiety and depression and a negative eFect on self-
esteem (Lai 2016; Tubaro 2004; Wein 2009). Ou 2019 reported that
people with lower urinary tract symptoms (LUTS) and depression
are at a greater risk of developing dementia. In a survey conducted
in 2017 (Rantell 2017), 88% of participants reported experiencing
symptoms for over 10 years. Participants reported negative eFects
on physical, social, domestic, occupational, and sexual domains.
Given the high prevalence of OAB, treatment costs are significant.
The National Overactive Bladder Evaluation Programme (NOBLE)
cited the cost of treating OAB in the USA in 2000 was USD 12.02
billion (Hu 2003). A further study estimated that the cost of
providing care would rise with an aging population; projected costs
for 2020 are USD 82.6 billion per annum (Ganz 2010).
OAB is usually diagnosed by a thorough history and physical
examination. Validated symptom questionnaires are used to
document and quantify symptoms, while clinical examination can
help exclude other causes of LUTS. A bladder diary can assess the
frequency and severity of symptoms (NICE 2019).
Description of the intervention
Initial treatment for OAB includes lifestyle modification, pelvic floor
exercises, and fluid management. Where these are unsuccessful,
people are oFered anticholinergic drugs or β3-adrenoreceptor
agonists. If medications do not control symptoms, then surgical
interventions may be required. Surgical treatment for OAB includes
intravesical botulinum toxin injection, sacral neuromodulation,
augmentation cystoplasty, and urinary diversion (NICE 2019).
Although acupuncture is not currently oFered universally as a
treatment for OAB, there is a growing body of literature that reports
positive outcomes when using this modality to treat the symptoms
of OAB (Aydoğmuş 2014; Yuan 2015; Zhao 2018).
Acupuncture refers to the practice of inserting multiple fine needles
throughout the body in order to achieve a positive physiological
response (White 2009). Needling can be performed within the
dermatome of the aFected area; at prominent acupoints found
throughout the body which, according to Traditional Chinese
Medicine (TCM) theory, have specific eFects on symptoms; on
the visible part of the ear (the auricle); and with the addition of
electrical stimulation (electroacupuncture).
Acupuncture is practised widely throughout Asia, Europe, and
Northern America and has a low adverse event risk profile, with
the most common adverse events being reported as transient
(Clarkson 2015; MacPherson 2001). Examples of adverse events
reported in the literature include bleeding at the site of needle
insertion, pain at the site of the inserted needle, or an initial
increase in pain at the site of injury (Witt 2009).
A typical acupuncture session may last between 15 to 40 minutes.
Needles may be stimulated, either manually by the clinician
(needles turned in the acupoint) periodically throughout the
session, or continually through an electroacupuncture device that
delivers an electrical current. The frequency and duration of
treatment may vary depending on clinician preference and patient
response.
How the intervention might work
While the exact mechanism of how acupuncture treats OAB remains
unclear, several theories exist. Sensory information from aFerent
nerves from the pelvic, pudendal, and hypogastric nerve roots
directly relate to the lower urinary tract (Pullman 2016). Needling
within the skin and muscles that these nerves supply may reduce
OAB through inhibition of peripheral nerves (Hino 2010), via brain
areas that control bladder activity (Wang 2012). Furthermore, the
Brain Bladder Control Matrix, where the periaqueductal gray, limbic
system, and prefrontal cortex are believed to have a large influence
upon the bladder’s function, have been found to alter during and
aLer a course of acupuncture (Dhond 2008; Huang 2012). This infers
that the beneficial eFects of acupuncture on OAB symptoms could
be partially explained through signalling changes from the central
nervous system to the bladder. Acupuncture has been shown to
exert an eFect on the autonomic nervous system (Napadow 2013),
further endorsing the view that acupuncture can influence the
human nervous system and therefore may aFect symptoms arising
from a disturbance in this system.
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In TCM theory, the maintenance of health and well-being is
dependent upon the quality of energy (Qi), which emanates from
the visceral organs. When Qi becomes unbalanced, symptoms of
ill health occur. In the case of OAB, this would be attributable
to deficient kidney and bladder Qi (Maciocia 2008). Acupoints
on the bladder, kidney, and spleen meridians are believed in
TCM theory to directly benefit urinary symptoms by restoring Qi
balance (Maciocia 2008). There is debate between acupuncture
practitioners regarding the concepts described and further high-
quality research is required to explore the putative mechanisms
underpinning the observed eFects of acupuncture.
Why it is important to do this review
There are specific concerns and side-eFects linked to some
treatments for OAB. The additive eFect of anticholingeric
medications may be linked to the development of dementia (Gray
2015). Surgical treatments are invasive, may be contraindicated, or
carry a significant risk in older people who are more likely to have
co-morbidities. Surgical interventions have a significantly higher
risk profile and recovery period when compared to acupuncture
(NICE 2019; Witt 2009). In light of this, it is important to investigate
alternative strategies for managing OAB.
Published Cochrane Reviews concerning treating OAB
include: anticholinergics (Madhuvrata 2012), implanted sacral
neuromodulation (Herbison 2009), onabotulinumtoxin A (Duthie
2011), and bladder training (Wallace 2004). Currently, the role
of acupuncture in the treatment of OAB has not been assessed
in a Cochrane Review. The eFicacy of acupuncture is uncertain,
there is no consensus with regard to treatment protocols, and it
is anticipated that some of the research available may be of poor
quality (Forde 2016). High-quality evidence is essential to allow
patients to make fully informed decisions regarding their choice
of therapies, and this Cochrane Review may highlight the need for
more high-quality research into acupuncture for OAB.
O B J E C T I V E S
To assess the eFects of acupuncture for treating OAB in adults; and
summarise the principal findings of relevant economic evaluations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs), quasi-RCTs,
and cross-over studies of acupuncture for treating OAB in adults.
By quasi-RCTs, we mean trials in which randomisation may be
predictable, such as the allocation of participants by day of the
week, date of birth, or sequence of entry into the trial.
Types of participants
We will include studies of adults aged over 18 years with a
diagnosis of OAB that fits the criteria defined by the International
Continence Society as "urinary urgency, usually accompanied
by frequency and nocturia, with or without urgency urinary
incontinence, in the absence of urinary tract infection or other
obvious pathology" (Abrams 2017).
This review is addressing treatment for idiopathic OAB and we will
therefore exclude participants who have OAB symptoms that are a
manifestation of a neurological condition (e.g. multiple sclerosis,
Parkinson's disease, and stroke).
Types of interventions
We will include studies of acupuncture interventions intended
to treat the symptoms of OAB that involve needle insertion at
defined acupuncture points. This includes body acupuncture, scalp
acupuncture, auricular acupuncture, and electro-acupuncture. We
will seek clarification from study authors if the type of acupuncture
used in a study is not clear.
Sham acupuncture is designed to assist with blinding participants
about the type of treatment they are receiving. It can be delivered
using a needle which appears to pierce the skin but does not, or by
inserting needles at non-acupuncture points.
We will include the following comparators.
• Acupuncture versus no treatment
• Acupuncture versus sham acupuncture
• Acupuncture versus conservative treatments (including bladder
retraining, fluid management, pelvic floor rehabilitation, weight
loss, and smoking cessation)
• Acupuncture versus medication for OAB
We believe that the comparisons of particular interest to patients
and practitioners are acupuncture versus no treatment or sham
acupuncture, and acupuncture versus medication for symptoms of
OAB.
Types of outcome measures
Primary outcomes
• Number of participants whose OAB symptoms were cured
or improved (assessed using validated urinary symptom
and incontinence-specific patient-reported outcome measures
(i.e. the Bristol Female Lower Urinary Tract Symptoms
questionnaire (BFLUTS) (Hiller 2002), International Consultation
on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI)
(Avery 2004), three-day bladder diaries (Jimenez-Cidre 2015).
Numbers of participants defined as cured in studies will be
reported. Where cure rates are not used, we will use symptom
improvement rates)
• Number of major adverse events (i.e. death, serious infection
from needle insertion, pneumothorax from needle insertion, any
complication resulting in hospitalisation as an inpatient or an
outpatient)
• Number of minor adverse events (i.e. fainting, vomiting, pain
on needle insertion, bleeding on needle removal, bruising, and
fatigue)
Secondary outcomes
• Presence or absence of urinary urgency (measured by patient-
reported outcomes)
• Daytime urinary frequency (i.e. number of voids during waking
hours measured by patient-reported outcomes)
• Episodes of urinary incontinence in a 24-hour period (measured
by patient-reported outcomes)
• Episodes of nocturia (i.e. number of voids aLer going to sleep
and prior to waking measured by patient-reported outcomes)
Acupuncture for treating overactive bladder in adults (Protocol)
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• Improvement in objective measures of urinary incontinence (i.e.
urodynamic testing parameters)
• Improvement in general quality of life (assessed using validated
scores i.e. EQ-5D (Rabin 2001), medical outcomes SF-36 (Ware
1992), ICEpop CAPability measure for Adults (ICECAP A) (Al-
Janabi 2013)
Timing of outcome assessment
We will include outcome measures that are applied as follows.
• Within three weeks of randomisation (baseline measurement)
• Within 12 weeks of commencing treatment (short-term
outcomes)
• Longer than 12 weeks aLer commencing treatment (long-term
outcomes)
Acupuncture treatments for OAB symptoms are usually applied on
at least a weekly basis. Studies vary in the number of treatments
given, with usual practice between 4 to 12 treatments. Acupuncture
is thought to have a carryover treatment eFect and so the
measurement of long-term outcomes is of interest in this review.
Main outcomes for ‘Summary of findings' tables
• Number of participants whose OAB symptoms were cured or
improved
• Number of major adverse events
• Number of minor adverse events
• Presence or absence of urinary urgency
• Daytime urinary frequency
• Episodes of urinary incontinence in a 24 hour period
• Episodes of nocturia (i.e. number of voids aLer going to sleep
and prior to waking)
Where not otherwise indicated, all outcomes for the ‘Summary of
findings' tables will be measured within 12 weeks of commencing
treatment (i.e. short-term).
Search methods for identification of studies
We will not impose any language or other limitations on any of the
searches described below.
Electronic searches
Search for clinical eectiveness studies
This review will draw on the search strategy developed for
Cochrane Incontinence. We will identify relevant trials from the
Cochrane Incontinence Specialised Register. For more details of the
search methods used to build the Specialised Register, please see
the Group's webpages where details of the Register's development
(from inception) and the most recent searches performed to
populate the Register can be found. To summarise, the Register
contains trials identified from the Cochrane Central Register
of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process,
MEDLINE Epub Ahead of Print, ClinicalTrials.gov, WHO ICTRP, NIHR
Be Part of Research and handsearching of journals and conference
proceedings. Many of the trials in the Cochrane Incontinence
Specialised Register are also contained in CENTRAL.
The terms that we will use to search the Cochrane Incontinence
Specialised Register are given in Appendix 2.
We will also search the Allied and Complementary Medicine
database (AMED) on OvidSP.
In addition, electronic bibliographic databases where knowledge of
the Chinese language is necessary will be searched.
• China National Knowledge Infrastructure (CNKI)
• Chinese Medical Literature Database (CBM)
• Chinese Medical Current Content (CMCC)
• VIP, and
• WANFANG (China Online Journals)
Search for economic evaluations
We will perform additional searches for the brief economic
commentary (BEC). We will search the:
• NHS Economic Evaluation Database (EED) on the UK Centre for
Reviews and Dissemination (CRD) website (covering from the
earliest record in NHS EED, dating from 1968, up to and including
31 December 2014 when their coverage ended)
As NHS EED is no longer actively updated, we will perform
additional searches of the following databases to identify eligible
studies added to these databases from 1 January 2015 onwards:
• MEDLINE on OvidSP (covering 1 January 1946 to the most recent
available version); and
• Embase (on OvidSP) (covering 1 January 1974 to the most recent
available version).
Details of the searches that will be performed can be found in
Appendix 3.
Searching other resources
We will search the reference lists of relevant articles and will use
these to identify economic evaluation studies. For the economic
evaluations included in the BEC, we will perform forward citation
searching.
Data collection and analysis
We will conduct data collection and analysis in accordance with
methods specified in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2019).
Selection of studies
As we anticipate that a proportion of studies will be available only in
Mandarin, four review authors will form pairs to select studies and
extract data (EH and CC for English-language studies; and YYZ and
one other (to be recruited) for Mandarin-language studies). Both
pairs of review authors will use the same soLware, and screening
and data extraction processes.
Using Covidence, the above pairs of review authors will
independently screen the titles and abstracts identified by the
search. We will obtain the full text of potentially relevant reports
and assess these against the review's inclusion criteria. Review
authors will compare and discuss their results, and will resolve
disagreements by consulting a third review author (KB).
Acupuncture for treating overactive bladder in adults (Protocol)
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Data extraction and management
Using Covidence, the above pairs of review authors will
independently extract the data from selected studies. We will
compare and discuss data extraction forms for each study. A third
review author (GB) will resolve any disagreements.
Assessment of risk of bias in included studies
We will use Cochrane's ‘Risk of bias' tool to assess the risk of bias in
included studies (Higgins 2011). The above pairs of review authors
will individually assess each of the identified studies against the six
domains (sequence generation, allocation concealment, blinding
of participants and study personnel, blinding of outcome assessors,
incomplete outcome data, selective outcome reporting, and any
other source of potential bias). For each domain, we will rate the
study as either at ‘high', ‘low', or ‘unclear' risk of bias. A third review
author (KB) will arbitrate any disagreements.
Measures of treatment e:ect
We will use Review Manager 5 (RevMan 5) to perform statistical
analysis of the data collected from selected studies (Review
Manager 2014). One review author (EH) will be responsible for data
entry into RevMan 5 and a second review author (CC) will check the
process.
For dichotomous outcome data, we will measure the treatment
eFect using risk ratios (RR) with 95% confidence intervals (CIs).
For continuous outcome data, we will use mean diFerence (MD)
values with 95% CIs to measure the treatment eFect. If the studies
identified use diFering scales to measure the same outcome, it may
be necessary to use the standardised mean diFerence (SMD) with
95% CIs.
Unit of analysis issues
We intend to include studies using a cross-over design if they meet
the inclusion criteria and will apply the guidance of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2019).
The risk of bias assessment will pay particular attention to the
dropout rate following first treatment, the randomisation process
to first treatment, and the reporting of these events. If the dropout
rate following the first treatment is high and the study reports first
treatment only data, we will exclude these studies. An assessment
of the eFect of carryover from treatment one to treatment two
will be made and, if it is felt that the treatment carryover would
significantly aFect reported results, these studies will be excluded
from the review.
If insuFicient detail is reported in studies to make the judgements
described above, we will contact study authors in order to obtain
the details required.
If there is a group of cross-over studies reporting the results
of a paired analysis (i.e. as a MD), we could use the generic
inverse-variance method (GIV) to perform a meta-analysis or meta
regression as required.
Dealing with missing data
We will include studies reporting results using an intention-to-treat
(ITT) analysis if the participants were analysed in the trial arm to
which they were originally assigned. If this information is not clear
from the trial report, we will contact study authors for clarification.
If there are missing data reported that could be calculated using
recognised statistical methods, we will perform these calculations.
The conventional analysis of meta-analysis will be used if only
individuals with available data are adequate and when we are
confident that the data are missing at random (MAR) in every
study (i.e. that the probability of missing data does not depend on
unobserved outcomes, conditional on observed variables).
However, if data are not missing at random, we will use two
methods based on plausible assumptions about the missing data.
We will impute missing values based on the distribution of reasons
for missing data. ALer specifying the magnitude and uncertainty
of possible departures from the missing at random assumption,
we will use these to correct bias and re-weight the studies
by employing a pattern mixture model and describing how the
outcome in the missing participants is related to the outcome in the
completers. This relationship will be informed using expert opinion
in the review author team.
Assessment of heterogeneity
We will assess the heterogeneity of studies by visually assessing
funnel plots and calculating the Chi2 and I2 statistics using RevMan
5 soLware (Review Manager 2014). This data will allow us to assess
heterogeneity and decide whether a meaningful meta-analysis can
be performed. The assessment of heterogeneity will be guided by
the Cochrane Handbook for Systematic Reviews of Interventions as
follows (Higgins 2019):
• 0% to 40%: might not be important
• 30% to 60%: may represent moderate heterogeneity
• 50% to 90%: may represent substantial heterogeneity
• 75% to 100%: considerable heterogeneity
Assessment of reporting biases
If suFicient studies are identified, we will produce a funnel plot to
explore publication bias.
Data synthesis
We will synthesise data collected using RevMan 5 (Review Manager
2014). We will generate forest plots and 95% CIs for each outcome
and will use a fixed-eFect model. However, if the data are
heterogeneous, we will use a random-eFects model. A meta-
analysis may not be possible if data is sparse and the level of
heterogeneity is very high. In this instance, we will undertake a
narrative synthesis of the results.
Subgroup analysis and investigation of heterogeneity
If the data allows, we will perform the following subgroup analyses.
• Sex (male versus female)
• Form of acupuncture (body acupuncture versus
electroacupuncture versus auricular)
• Age (under 65 years versus over 65 years)
Sensitivity analysis
If the eligibility of some included studies is dubious (i.e. if they have
missing data), it may be necessary to perform a sensitivity analysis
to assess the robustness of the results. We will complete this at the
end of the data analysis process if indicated for studies with a high
risk of bias.
Acupuncture for treating overactive bladder in adults (Protocol)
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If the data allows, we will also perform a cumulative meta-analysis
using Stata soLware (Stata 2019), where studies are added one at a
time in a specified order according to date of publication or quality
to check the contribution of added studies.
Summarising findings and assessing certainty of the evidence
We will use the GRADE approach to assess the certainty of evidence
related to the ‘Main outcomes for ‘Summary of findings' tables'
as listed in the Types of outcome measures (Schünemann 2019).
We will use the five GRADE considerations (study limitations,
consistency of eFect, imprecision, indirectness, and publication
bias). We will justify all decisions to downgrade the certainty of
studies using footnotes. Two review authors will undertake this
work (EH and GB).
We will prepare ‘Summary of findings' tables using the GRADEpro
soLware for the main comparisons pre-stated in the Types of
interventions if there is suFicient evidence (GRADEpro GDT).
Incorporating economics evidence
Following the search outlined in the Search methods for
identification of studies, we will develop a BEC to summarise
the availability and principal findings of the full economic
evaluations that compare acupuncture with other treatments
(Shemilt 2019). This BEC will encompass full economic evaluations
(i.e. cost-eFectiveness analyses, cost-utility analyses, and cost-
benefit analyses) conducted as part of a single empirical study, such
as a RCT, a model based on a single such study, or a model based
on several such studies.
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A P P E N D I C E S
Appendix 1. Glossary of terms
Acetylcholine: a substance that transmits nerve impulses within the central and peripheral nervous systems.
Acupuncture: a treatment derived from ancient Chinese medicine. Fine needles are inserted at certain sites in the body for therapeutic
or preventative purposes.
Acupuncture point: a point of the body where an acupuncture needle may be inserted. Acupuncture points are identified by anatomical
landmarks and palpation.
Acupoint: a shorthand way of referring to an acupuncture point.
A:erent nerve: a nerve that bring information from the body to the brain.
Anticholingeric: a substance that blocks the action of the neurotransmitter acetylcholine at synapses in the central and the peripheral
nervous system. Medications used to treat symptoms of overactive bladder (OAB) include anticholinergic agents.
Augmentation cystoplasty: a procedure that involves making the bladder bigger by adding a piece of tissue from the intestine into the
bladder wall. This may improve the ability of the bladder to store urine. It is rarely performed for symptoms of OAB and is viewed as a
treatment of last resort.
Bladder Brain Control matrix: the complex nerve pathways governing bladder function.
Bladder retraining: the first-line treatment for urinary symptoms associated with OAB. It involves teaching the bladder to hold more urine
and helps to reduce urinary frequency.
β3-adrenoreceptor agonists: a medication that relaxes smooth muscle and so can have a beneficial eFect on OAB symptoms.
Co-morbidities: the presence of one or more additional conditions co-occurring with a primary condition.
Dermatome: an area of sensory nerves near the skin that are supplied by a specific spinal nerve root. The body can be divided into regions
that are mainly supplied by a single spinal nerve. Dermatomes are named according to their spinal nerve root.
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Economic evaluation: the application of analytical methods to identify measure and value both the costs and benefits of alternative
interventions in order to provide evidence regarding technical or allocative eFiciency and aid decision making for resource allocation
(definition taken from the Campbell and Cochrane Economics Methods Group's Glossary) .
E:erent nerve: a nerve that brings information from the brain to the body.
Electroacupuncture: an acupuncture technique that applies small electrical currents to needles that have been inserted at specific points
on the body.
Intravesical botulinum toxin injection: a form of treatment where botulinum toxin is injected into the smooth muscle of the bladder wall
(the detrusor muscle) in order to treat symptoms of OAB.
Limbic system: interconnected structures in the midline of the brain involved with emotion, memory and regulatory systems.
Meridians: a concept in Traditional Chinese Medicine (TCM) about a path through which the life-energy known as "Qi" flows.
Nocturia: the number of times urine is passed during the main sleep period.
Overactive bladder (OAB): a group of symptoms aFecting the urinary system that includes urinary urgency (a sudden and intense desire
to pass urine that is hard to defer), frequency (passing urine more frequently than 5 to 8 times in a 24-hour period), nocturia (waking to
pass urine at night), urinary incontinence (involuntary passing urine).
OAB-dry: OAB symptoms without urinary incontinence.
OAB-wet: OAB symptoms with urinary incontinence.
Orbitofrontal cortex: a region in the frontal lobes of the brain that is involved in the cognitive process of decision-making.
Pre-frontal cortex: the anterior part of the frontal lobe of the brain, which is highly developed in humans and concerned with complex
cognitive, emotional, and behavioural functions.
Peri-aqueductal gray (PAG): a mid-brain structure that plays a critical role in autonomic function and behavioural responses to
threatening stimuli.
Qi: believed to be a vital force forming part of any living entity in TCM.
Traditional Chinese Medicine (TCM): a system of medicine traditionally practised in China; acupuncture is one component of this system.
Sacral neuromodulation: a form of treatment where a small nerve stimulator device is implanted in the body to provide stimulation to
the sacral nerves. This stimulation is thought to have an eFect on the nerves passing between the bladder and the brain and relieve the
symptoms of OAB.
Smooth muscle: a type of muscle tissue that contracts without conscious control. The detrusor muscle that forms the bladder wall is made
of smooth muscle.
Urinary diversion: a procedure where the tubes that lead from the kidneys to the bladder (ureters) are redirected to outside of the body.
The urine is then collected directly without it flowing into the bladder. Urinary diversion is only performed if other treatments have been
unsuccessful or are unsuitable.
Urinary incontinence (UI): involuntary passing of urine.
Urothelial cells: the cells that form the lining of the bladder.
Appendix 2. Search of the Cochrane Incontinence Specialised Register






All searches will be of the keywords field of EndNote (EndNote 2018).
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Appendix 3. Search methods for the brief economic commentary (BEC)
We will perform electronic searches designed to identify published reports of relevant economic evaluations to inform the BEC (see
‘Incorporating economic evidence' in the Methods). We will search the:
• NHS Economic Evaluation Database (EED) on the UK Centre for Reviews and Dissemination (CRD) website (covering from the earliest
record in NHS EED, dating from 1968, up to and including 31 December 2014 when their coverage ended)
As the NHS EED is no longer actively updated, we will perform additional searches of the following databases to identify eligible studies
added to these databases from 1 January 2015 onwards:
• MEDLINE on OvidSP (covering 1 January 1946 to the most recent available version); and
• Embase (on OvidSP) (covering 1 January 1974 to the most recent available version).
The economic evaluation search filters which will be applied to our MEDLINE and Embase search strategies will be those formerly used
by the CRD to identify published reports of full economic evaluations for indexing on NHS EED. These economic evaluation search filters
remain freely available on the CRD Database search strategies webpage (CRD 2015). The other search lines in the MEDLINE and Embase
search strategies will be adapted from the electronic search strategies run for our Cochrane Incontinence Specialised Register, along with
additional terms for this population developed specifically for this Cochrane Review. Similarly, our NHS EED search strategy will be adapted
from search strategies run for our Specialised Register and based on textword and MeSH terms (capturing relevant P-I-C concepts) used to
identify eligible studies of intervention eFects. We will follow the current economic methods guidance (Shemilt 2019).
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